FATE THERAPEUTICS INC FATE
CIK 0001434316
Form 4 transactions dated Nov 1, 2023 to Nov 7, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $834.60K
- Sold
- $1.27M
Nov 1, 2023 – Nov 4, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| Dec 20, 2024 | Redmile Group, LLC · Green Jeremy Director · 10% owner | Sale | $573.94K 341,633 shares sold | Unavailable Indirect holding | ▾ |
| Dec 20, 2024 | Redmile Group, LLC · Green Jeremy Director · 10% owner | Purchase | $668.58K 397,964 shares bought | Unavailable Indirect holding | ▾ |
| Aug 6, 2024 | Xu Yuan Director | Sale10b5-1 footnote | $2.68K 633 shares sold | 6.80% sold Direct holding | ▾ |
| Mar 4, 2024 | Dulac Edward J III Chief Financial Officer | Sale10b5-1 footnote | $19.01K 2,447 shares sold | 2.35% sold Direct holding | ▾ |
| Jan 29, 2024 | Dulac Edward J III Chief Financial Officer | Sale10b5-1 footnote | $9.24K 1,849 shares sold | 1.75% sold Direct holding | ▾ |
| Jan 9, 2024 | TAHL CINDY General Counsel and Secretary | Sale | $47.52K 10,874 shares sold | 7.10% sold Direct holding | ▾ |
| Jan 9, 2024 | Valamehr Bahram Chief R&D Officer | Sale | $49.37K 11,271 shares sold | 6.66% sold Direct holding | ▾ |
| Jan 9, 2024 | Wolchko J Scott President and CEO · Director | Sale | $62.89K 14,391 shares sold | 3.73% sold Direct holding | ▾ |
| Jan 9, 2024 | Dulac Edward J III Chief Financial Officer | Sale | $30.71K 7,028 shares sold | 6.23% sold Direct holding | ▾ |
| Jan 2, 2024 | Dulac Edward J III Chief Financial Officer | Sale10b5-1 footnote | $18.97K 5,182 shares sold | 4.39% sold Direct holding | ▾ |
Showing 10 / 10 record groups in 2024. The complete set is available through the API.
Follow the people behind the trades.
Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
+ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 10 of 10 purchase / sale groups and 24 of 24 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_insider_transactions
{"action":"list","ticker":"FATE","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.